GSA Capital Partners »

Context Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $89k 160k 0.56
2024-12-31 $28k 27k 1.03

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Shor Corp Etf (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Agree Realty Corporation (ADC)
Bank Ozk (OZK)
PNM Resources (TXNM)
Essential Properties Realty reit (EPRT)
TJX Companies (TJX)
Everest Re Group (EG)
O'reilly Automotive (ORLY)
American Airls (AAL)
Medtronic SHS (MDT)
Northrop Grumman Corporation (NOC)

View all positions for GSA Capital Partners

Top funds holding Context Therapeutics

Nextech Invest
Deep Track Capital
Soleus Capital Management
BlackRock
Avidity Partners Management
Franklin Resources
Vanguard Capital Management
Octagon Capital Advisors
Blue Owl Capital Holdings
TCG Crossover Management
Geode Capital Management
MPM Oncology Impact Management
Renaissance Technologies
Acadian Asset Management
ADAR1 Capital Management

View all funds holding Context Therapeutics